Sponsored Content | Case Study | Radiation Oncology | September 04, 2019

First Clinical Experience With the RayCare OIS

Iridium Cancer Network

Iridium Cancer Network

Piet Dirix

Piet Dirix

Iridium Cancer Network consists of all seven hospitals in the Antwerp region, closely collaborating regarding radiation oncology. The network acts as a single radiation therapy department, making it the largest in Belgium with its annual 5,300 patients. Iridium was first to use the RayCare* oncology information system (OIS) clinically, only two months after it was released from RaySearch.

Iridium Cancer Network became a RaySearch customer in 2015 when choosing RayStation for its treatment planning. Iridium quickly appeared as an obvious choice of clinical partner to develop RayCare, the next-generation OIS, as the department spreads over seven hospitals. This, combined with a strong interest for clinical innovation, made the network a very attractive partner to develop aspects of RayCare related to coordinating cancer care efforts between institutions.

It made perfect sense to help RaySearch develop such an OIS, said Piet Dirix, radiation oncologist at Iridium.

“For me, the partnership with RaySearch was an absolute no-brainer. We needed to have an OIS that we could trust and that would help us tremendously with our workflow. Hearing that RaySearch was developing such an OIS and that they were actually looking for clinical partners to develop it with them, I became incredibly enthusiastic and we really wanted to participate in that,” he said.

Seamless Integration With RayStation

Iridium became a clinical partner to RaySearch in late 2015 and has since made a strong contribution to develop RayCare, especially with features that will support coordinated activities between different institutions. The first steps of the clinical use were done with a focus on planning workflow support and image management using RayPACS, a picture archiving and communication system (PACS) that makes it fast and easy to retrieve and share images.

“With RayCare, we can just label an image in RayPACS and then the system handles the import from RayPACS to RayStation. When launching RayStation, the patient information is there, your CT is there and you can start work directly with your patient. This is a big improvement,” Gert De Kerf, medical physics expert, said.

The tight integration between RayCare and RayStation simplifies the teamwork between clinicians, especially when different clinicians can be working on a single patient at different steps of the treatment process.

“Here at Iridium we work as a team to treat the patients. So, it is possible that I delineate a CT scan, that my colleague approves a plan, and another revises the adjustments that are made to the plan. In that way, RayCare is very crucial to the way we work,” said Carole Mercier, radiation oncologist.

“Before the implementation of RayCare we had some problems with commenting when a plan was rejected. Now, thanks to RayCare and the feedback loops, this is simplified,” De Kerf said.

The seamless integration between the systems is great, said Dirix.

“What I am most satisfied with is the close interaction with RayStation. When I push on a certain task in RayCare, RayStation immediately opens at the right patient, in the right time of his or her workflow. This really saves time,” he said.

After a few months of using the RayCare OIS they can already note some efficiency improvements. RayCare and RayStation are used together on one Linac at Iridium, which is actually the linac with the shortest waiting time within the network, according to Dirix.

“There are now around three days wait at the machine where we have RayCare and RayStation, compared to around 21 days at the other linacs. This shows you how powerful the combination is,”
Piet said.

Simplified Workflow

On top of the close interaction with RayStation, RayCare provides other valuable advantages. It has simplified the patient intake consultation process and reduced issues from 25 to 5 percent. RayCare’s schedule automation feature made it much simpler to find the optimal treatment date, eliminating the delays that could result from the complexity of the manual scheduling.

RayCare has been developed by RaySearch to meet the ends of the needs of diverse cancer centers to enable them to give the best possible care to their patients. Therefore, in RayCare digital workflows tailored to the clinic’s needs can be created. The workflows are designed to be highly configurable and tasks for specific staff members can be created automatically, triggered by defined events.

The workflows used at Iridium are custom made and set up in collaboration between Iridium and RaySearch. Six workflows for five tumor groups were specified to Iridium’s needs, with a focus on automation and optimization.

“On the stereotactic treatments we treat five different tumor groups and for these patients six workflows were created. They were all made to our specific needs; for example, we needed an anchor date for an MRI. RayCare now has an anchor date for the MRI,” said Mercier.

Comprehensive Cancer Care is the Future

Centers today often use multiple software systems, including systems for radiation oncology, medical oncology and surgical oncology. The aim with RayCare is to combine these into a single, harmonized system to manage the patient’s entire oncology treatment — from scheduling through treatment delivery and follow-up.

Iridium shares that same ultimate vision of a borderless oncology environment and the future results of the partnerships look very promising.

“I think the future of cancer care will be comprehensive. I think we have to break down the walls between radiation oncology, medical oncology, surgery and especially pathology. These need to be incorporated into a single OIS, and that is exactly what RayCare allows you to do,” said Dirix.

* Subject to regulatory clearance in some markets.

Related Content

Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association

Getty Images

News | Prostate Cancer | September 08, 2020
September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the h
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer